Weakness+exertion on physical activity+burning sensation in foot
| Type | Key Features |
|---|---|
| Diabetic neuropathy | Symmetric polyneuropathy; burning dysesthesias and pain in soles; mild distal motor weakness; impaired position sense; autonomic features (postural hypotension, gastroparesis) |
| Uremic neuropathy | Symmetric sensorimotor; burning paresthesias; in CKD patients |
| Nutritional/B-vitamin deficiency | Burning feet + weakness + hyporeflexia; symmetric; seen with alcoholism, malabsorption, unusual diet |
| Alcoholic neuropathy | Axonal sensorimotor; burning feet; due to thiamine/B12 deficiency |
| Cryptogenic sensory polyneuropathy | Burning pain beginning in feet; distal sensory loss; weakness NOT prominent; diagnosis of exclusion (~50% of cases) |
| CIDP | Proximal + distal weakness; progressive/relapsing; reduced DTRs; immune-mediated |
An inability to perform sudden intense exercise → problem with glycogenolysis/glycolysis. Inability at sustained levels → FAO defect.
| Diagnosis | Clue |
|---|---|
| Spinal stenosis / neurogenic claudication | Weakness + burning in legs on walking; relieved by sitting/forward flexion |
| Hypothyroidism | Weakness, fatigue, exercise intolerance; can cause neuropathy |
| Iron deficiency anemia | Weakness, exercise intolerance, dyspnea on exertion |
| Mitochondrial neuropathy | Weakness + sensory neuropathy + systemic features |
| Amyloid polyneuropathy | Autonomic dysfunction without diabetes; painful small-fiber neuropathy |

| Investigation | Purpose |
|---|---|
| FBS / HbA1c | Diabetes (most common cause) |
| Renal function (BUN, creatinine) | Uremic neuropathy |
| CBC | Anemia |
| Serum B12, folate, thiamine | Nutritional neuropathies |
| TSH | Hypothyroidism |
| Serum protein electrophoresis | Paraprotein/amyloid |
| ABI (ankle-brachial index) | PAD/claudication |
| Nerve conduction study + EMG | Confirms neuropathy; axonal vs. demyelinating; localization |
| CK level | Myopathy (elevated in McArdle disease, inflammatory myopathy) |
| Forearm ischemic exercise test | If GSD/McArdle suspected (lack of lactate rise) |
Ask me questions and get me a diagnosis based on this
Male 26 yrs
| Feature | Significance |
|---|---|
| 26-year-old male | Young → acquired/nutritional cause, not degenerative |
| Distal leg weakness, constant | Length-dependent sensorimotor neuropathy |
| Burning feet, worse at night | Small-fiber neuropathy — classic B12/thiamine pattern |
| Burning pain without numbness | Early/pure small-fiber involvement, large fibers preserved |
| Normal gait, no balance issues | Proprioception (large fiber) still intact |
| Poor/irregular diet | Primary risk factor for B-vitamin deficiency |
| Weight loss / poor appetite | Compounds nutritional deficiency; also a red flag |
| Moderate alcohol use | Even moderate alcohol impairs B-vitamin absorption and metabolism |
| >6 months duration | Chronic course consistent with gradual nutritional depletion |
| No family history | Rules out hereditary neuropathy (CMT, etc.) |
"Most nutritional neuropathies involve one of the B-complex vitamins. Patients at risk usually have chronic alcoholism, malabsorption syndrome, eating disorder, or unusual diet (food faddist). It presents as a symmetric polyneuropathy with burning in the feet. Weakness, atrophy, and hypoactive reflexes may also occur." — Textbook of Family Medicine 9e, p. 1247
| Test | Why |
|---|---|
| Serum Vitamin B12 | Most important first test |
| Serum Thiamine (B1) | Dietary deficiency |
| Folate, B6 | Complete B-vitamin screen |
| CBC + peripheral smear | Macrocytic anemia from B12/folate deficiency |
| HbA1c / FBS | Exclude diabetes |
| Anti-tTG IgA + total IgA | Celiac disease (malabsorption) |
| HIV serology | Given age + weight loss |
| LFTs, GGT | Alcohol-related liver disease affecting absorption |
| Nerve conduction study + EMG | Confirm axonal sensorimotor neuropathy |
| Skin punch biopsy (intraepidermal nerve fiber density) | Gold standard for small-fiber neuropathy if NCS normal |
⚠️ Disclaimer: This is a clinical reasoning exercise to support — not replace — a physician's evaluation. A formal diagnosis requires physical examination, nerve conduction studies, and laboratory confirmation.
Give me a differential diagnosis
| Why likely | Poor diet + moderate alcohol = reduced B12/thiamine intake AND impaired absorption. Classic presentation: burning feet worse at night, distal weakness, symmetric, chronic course |
| Subtype | Thiamine (B1) deficiency → axonal sensorimotor neuropathy; B12 deficiency → small-fiber burning pain before large-fiber signs appear |
| Supporting | Young age, no family history, acquired risk factors, weight loss (reduced intake) |
| Against | Alcohol use is only moderate, not heavy |
| Key test | Serum B12, thiamine, folate; CBC (macrocytosis) |
| Why likely | 26-year-old male + weight loss + burning feet = classic HIV-DSP triad. Occurs in ~30% of AIDS patients. Burning feet with painful paresthesias is the hallmark onset |
| Mechanism | Direct HIV neurotoxicity to dorsal root ganglia + small fibers |
| Supporting | Age, sex, weight loss, burning feet without prominent numbness |
| Against | No other HIV risk factors explicitly stated |
| Key test | HIV serology (ELISA + confirmatory Western blot) |
| Why likely | Weight loss + poor absorption of nutrients even on a diet → B-vitamin malabsorption. Celiac neuropathy can precede GI symptoms |
| Mechanism | Malabsorption of B12, B1, B6 → neuropathy; direct immune-mediated gluten neuropathy also possible |
| Supporting | Weight loss, poor nutritional status despite eating |
| Against | No GI symptoms reported |
| Key test | Anti-tTG IgA antibodies, total IgA; small bowel biopsy |
| Why less likely | CIDP typically causes proximal + distal weakness and is predominantly motor; burning pain is not a dominant feature |
| Why still consider | Young adult, chronic (>6 months) course, progressive weakness |
| Key test | Nerve conduction study (demyelinating pattern: slowed conduction velocity, prolonged distal latencies); CSF protein elevated |
| Why consider | Pre-diabetes (impaired glucose tolerance) can cause small-fiber neuropathy before frank diabetes develops; burning feet + distal weakness is the classic pattern |
| Why less likely | 26 years old, no stated family history of diabetes, no polyuria/polydipsia |
| Key test | HbA1c, fasting glucose, 2-hr oral glucose tolerance test |
| Why consider | Alcohol impairs thiamine/B6 absorption even at moderate intake; axonal sensorimotor neuropathy with burning feet |
| Why less likely | Intake is 4–5 times/month — typically requires heavy chronic use; however, combined with poor diet, it amplifies nutritional deficiency |
| Key test | GGT, LFTs, serum thiamine |
| Why consider | Young age + chronic course; some hereditary neuropathies (e.g., CMT2, hereditary small-fiber neuropathy with SCN9A/SCN10A mutations) present in young adults |
| Why unlikely | No family history, acquired risk factors fully explain the picture |
| Key test | Genetic panel if all acquired causes excluded |
| Rank | Diagnosis | Probability | Key Distinguishing Test |
|---|---|---|---|
| 1 | Nutritional (B12/Thiamine) Neuropathy | ⭐⭐⭐⭐⭐ High | Serum B12, thiamine, CBC |
| 2 | HIV-Associated DSP | ⭐⭐⭐⭐ Must exclude | HIV serology |
| 3 | Celiac/Malabsorption Neuropathy | ⭐⭐⭐ Moderate | Anti-tTG IgA |
| 4 | CIDP | ⭐⭐ Low-moderate | NCS/EMG |
| 5 | Pre-diabetic Neuropathy | ⭐⭐ Low-moderate | HbA1c, OGTT |
| 6 | Alcoholic Neuropathy | ⭐⭐ Contributing | GGT, LFTs |
| 7 | Hereditary Neuropathy | ⭐ Unlikely | Genetic testing |
Tell.me how you arrived at this diagnosis
| Eliminated | Why |
|---|---|
| Type 2 diabetic neuropathy | Rare at 26 without obesity/family history |
| Degenerative spine disease | Uncommon this young |
| Peripheral arterial disease | Rare under 40 without risk factors |
| Fiber Type | Sensation Carried | Status in this Patient |
|---|---|---|
| Large myelinated (Aβ) | Touch, vibration, proprioception → numbness when damaged | Intact |
| Small myelinated (Aδ) | Sharp pain, temperature → burning when damaged | Affected |
| Unmyelinated (C) | Dull/burning pain → burning when damaged | Affected |
| Factor | Effect |
|---|---|
| Poor/irregular diet | Reduced B12, thiamine, B6 intake |
| Moderate alcohol | Impairs thiamine absorption in gut; increases B-vitamin utilization |
| Weight loss/poor appetite | Further reduces intake |
Opening triad
↓
Age 26M → Eliminates PAD, DM2, degenerative
↓
Constant weakness → Eliminates metabolic myopathy, claudication
↓
Distal legs only → Points to length-dependent polyneuropathy
↓
Burning worse at night → Small-fiber neuropathy confirmed
↓
No numbness → Large fibers intact = pure small-fiber pattern
↓
Normal gait → Confirms large fibers spared
↓
Weight loss → Red flag: nutritional deficiency OR systemic illness
↓
Duration >6 months → Chronic acquired process
↓
Poor diet + moderate alcohol → Nutritional B-vitamin deficiency mechanism
↓
No family history → Hereditary causes excluded
↓
PRIMARY DIAGNOSIS: Nutritional (B12/Thiamine) Neuropathy
MUST EXCLUDE: HIV-DSP, Celiac/Malabsorption
| Diagnosis | Eliminated Because |
|---|---|
| McArdle / metabolic myopathy | Weakness is constant, not exercise-induced |
| Vascular claudication | Constant weakness, young age, no vascular risk factors |
| GBS | >6 months duration; GBS is acute (days–4 weeks) |
| CMT / hereditary neuropathy | No family history; clear acquired risk factors |
| Diabetic neuropathy | Age 26, no diabetes history or risk factors stated |
| CIDP | Typically proximal + distal weakness; burning pain not dominant; demyelinating on NCS |
But patient have proteinuria
| Before proteinuria | After proteinuria |
|---|---|
| Nutritional neuropathy (primary) | Still possible, but now a consequence of something bigger |
| HIV — must exclude | Now even more urgent to exclude |
| Celiac disease | More likely (malabsorption → proteinuria from nutritional losses) |
| Uremic neuropathy | Now actively enters the differential |
| Amyloidosis | Jumps to top 2 |
| Symptom | Amyloidosis Explanation |
|---|---|
| Burning feet worse at night | Painful dysesthesia — amyloid deposits along peripheral nerves; pain and temperature lost first (small fibers) |
| Distal weakness | Progressive axonal polyneuropathy |
| No numbness (yet) | Vibration/touch lost later — small fibers affected first |
| Proteinuria | Renal amyloidosis → glomerular amyloid deposits → proteinuria is the hallmark renal manifestation |
| Weight loss / poor appetite | Systemic amyloid burden; GI involvement |
| Chronic >6 months | Chronic progressive course |
"The neuropathy begins with painful dysesthesias in the legs and follows a chronic progressive course. Pain and temperature sensation are lost before light touch or vibratory sensation... Renal amyloidosis usually manifests as proteinuria and renal failure." — Bradley and Daroff's Neurology, p. 2683
"Patients with glomerular kidney involvement generally have proteinuria... [AL amyloidosis features include] significant proteinuria, neuropathy, periorbital purpura, and macroglossia." — Harrison's Principles of Internal Medicine 22E
"The neuropathy takes the form of a painless, progressive, symmetrical sensorimotor paralysis of the legs. In some patients, the syndrome begins with burning dysesthesias of the feet, worse at night." — Adams and Victor's Principles of Neurology
| Priority | Diagnosis | Unifying Feature |
|---|---|---|
| 1 | Amyloidosis (AL/ATTR) | Neuropathy + proteinuria + weight loss in same disease |
| 2 | Diabetes (T1/T2) — nephropathy + neuropathy | Most common cause of both together |
| 3 | HIV — HIVAN + DSP | Both renal and nerve involvement known |
| 4 | Uremic neuropathy from CKD | Proteinuria → CKD → uremic neuropathy |
| 5 | Nutritional neuropathy | Secondary to systemic illness |
| Test | Looking For |
|---|---|
| Serum + urine protein electrophoresis (SPEP/UPEP) | Monoclonal light chains → AL amyloidosis |
| Serum free light chains (κ/λ ratio) | Most sensitive for AL amyloid |
| HbA1c + fasting glucose + C-peptide | Diabetes (T1/T2) |
| HIV serology | HIVAN + HIV neuropathy |
| Serum creatinine, BUN, eGFR | Degree of renal failure |
| 24-hour urine protein / spot urine ACR | Quantify proteinuria |
| Abdominal fat pad aspiration (Congo red stain) | Amyloid diagnosis — ~80% yield |
| Echocardiogram | Amyloid cardiomyopathy |
| Nerve conduction study + EMG | Confirm axonal neuropathy pattern |
| Sural nerve + muscle biopsy | Gold standard for amyloid neuropathy (>90% yield) |
But patient have proteinuria
| This Patient | Fabry Disease |
|---|---|
| Male, 26 years old | X-linked disorder — males affected more severely; onset in late childhood to early adult life |
| Burning feet, worse at night | "Burning or lancinating pain in the hands and feet often develops in males in late childhood or early adult life" — Harrison's 22E |
| No numbness (small fiber only) | Fabry neuropathy is a pure small-fiber neuropathy — pain/temperature affected, large fibers spared initially |
| Distal leg weakness | Neuropathy + premature vascular disease affect limb function |
| Moderate proteinuria (2+) + frothy urine | Ceramide accumulation in podocytes and renal tubular cells → glomerular damage → proteinuria |
| Hypertension | "Premature atherosclerosis — hypertension, renal failure, cardiac disease, and stroke" — classic Fabry vascular complications |
| Weight loss | Systemic disease burden; GI involvement (Fabry affects autonomic GI nerves) |
| No skin rash reported | Angiokeratomas (around umbilicus, scrotum, inguinal region) — may be subtle or not yet looked for |
"Burning or lancinating pain in the hands and feet often develops in males in late childhood or early adult life. The neuropathy is usually overshadowed by complications arising from premature atherosclerosis — hypertension, renal failure, cardiac disease, and stroke — that often lead to death by the fifth decade." — Harrison's Principles of Internal Medicine 22E, p. 3645
"Fabry disease is an X-linked disease caused by mutations in the alpha-galactosidase gene GLA, leading to accumulation of globotriaosylceramide (GL3) in blood vessels and tissues, including podocytes... causing proteinuria and kidney disease." — Brenner and Rector's The Kidney
Deficiency of α-galactosidase A
↓
Accumulation of GL3 (globotriaosylceramide) in:
├── Small nerve fibers → Burning feet (small-fiber neuropathy)
├── Renal podocytes/endothelium → Proteinuria, hypertension
├── Vascular smooth muscle → Premature hypertension, atherosclerosis
├── GI autonomic nerves → Weight loss, poor appetite
└── Cardiac muscle → Cardiomyopathy (future risk)
| Before proteinuria | Thinking |
|---|---|
| Burning feet + weakness + poor diet | Nutritional neuropathy (B12/thiamine) |
| Weight loss | Nutritional depletion |
| After proteinuria + hypertension | Thinking |
|---|---|
| Burning feet + proteinuria + HTN in young male | Fabry disease — X-linked lysosomal storage disorder |
| No edema despite proteinuria | GL3 nephropathy — early/moderate stage, not yet nephrotic |
| No skin rash mentioned | Angiokeratomas may be subtle — need to actively look |
| Test | Expected Finding |
|---|---|
| Plasma α-galactosidase A activity (leukocytes) | Severely reduced or absent — diagnostic in males |
| Plasma/urine GL3 (globotriaosylceramide) | Elevated |
| GLA gene sequencing | Pathogenic mutation confirmed |
| Renal biopsy (EM) | Zebra bodies / myelin figures in podocytes |
| Skin biopsy | GL3 deposits in sweat glands and vessels |
| Echocardiogram | LVH, Fabry cardiomyopathy screening |
| Ophthalmology | Cornea verticillata (whorled opacities) — pathognomonic |
Try again
Generate a clinical summary document of this case for reference